Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311

Goldstein, 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition, Proc. Natl. Acad. Sci. USA., 76, 333, 10.1073/pnas.76.1.333

Fogelman, 1980, Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages, Proc. Natl. Acad. Sci. USA., 77, 2214, 10.1073/pnas.77.4.2214

Henriksen, 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins, Proc. Natl. Acad. Sci. USA., 78, 6499, 10.1073/pnas.78.10.6499

Witztum, 1991, Role of oxidized low density lipoprotein in atherogenesis, J. Clin. Invest., 88, 1785, 10.1172/JCI115499

Esterbauer, 1992, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free. Radic. Biol. Med., 13, 341, 10.1016/0891-5849(92)90181-F

Navab, 1996, The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture, Arterioscler. Thromb. Vasc. Biol., 16, 831, 10.1161/01.ATV.16.7.831

Berliner, 1996, The role of oxidized lipoproteins in atherogenesis, Free. Radic. Biol. Med., 20, 707, 10.1016/0891-5849(95)02173-6

Heinecke, 1984, Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture, J. Clin. Invest., 74, 1890, 10.1172/JCI111609

Morel, 1984, Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation, Arteriosclerosis, 4, 357, 10.1161/01.ATV.4.4.357

Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Natl. Acad. Sci. USA., 81, 3883, 10.1073/pnas.81.12.3883

Daugherty, 1988, Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits, Arteriosclerosis, 8, 768, 10.1161/01.ATV.8.6.768

Yla-Herttuala, 1989, Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man, J. Clin. Invest., 84, 1086, 10.1172/JCI114271

Haberland, 1988, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits, Science, 241, 215, 10.1126/science.2455346

Rosenfeld, 1990, Distribution of oxidation specific lipid-protein adducts and apolipoprotein-B in atherosclerotic lesions of varying severity from WHHL rabbits, Arteriosclerosis, 10, 336, 10.1161/01.ATV.10.3.336

Lynch, 1994, Antioxidants as anti-atherogens: animal studies

Steinberg, 1995, Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?, Lancet, 346, 36, 10.1016/S0140-6736(95)92657-7

Diaz, 1997, Antioxidants and atherosclerotic heart disease, New. Eng. J. Med., 337, 408, 10.1056/NEJM199708073370607

Frei, 1988, Antioxidant defenses and lipid peroxidation in human blood plasma, Proc. Natl. Acad. Sci. USA., 85, 9748, 10.1073/pnas.85.24.9748

Parthasarathy, 1986, Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor, Arteriosclerosis, 6, 505, 10.1161/01.ATV.6.5.505

Hiramatsu, 1987, Superoxide initiates oxidation of low density lipoprotein by human monocytes, Arteriosclerosis, 7, 55, 10.1161/01.ATV.7.1.55

Ehrenwald, 1994, Intact ceruloplasmin oxidatively modifies low density lipoprotein, J. Clin. Invest., 93, 1493, 10.1172/JCI117127

Mukhopadhyay, 1997, Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces, Proc. Natl. Acad. Sci. USA., 94, 11546, 10.1073/pnas.94.21.11546

Heinecke, 1986, Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells, J. Clin. Invest., 77, 757, 10.1172/JCI112371

Heinecke, 1987, The role of sulfur containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells, J. Biol. Chem., 262, 10098, 10.1016/S0021-9258(18)61082-8

Lynch, 1993, Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein, J. Lipid. Res., 34, 1745, 10.1016/S0022-2275(20)35737-0

Sparrow, 1993, Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions, J. Lipid. Res., 34, 1219, 10.1016/S0022-2275(20)37709-9

Heinecke, 1993, Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms, J. Lipid. Res., 34, 2051, 10.1016/S0022-2275(20)35347-5

Lynch, 1997, Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein, Biochem. Biophys. Acta., 1345, 215, 10.1016/S0005-2760(96)00182-8

Bowry, 1993, Tocopherol-mediated peroxidation: the prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein, J. Am. Chem. Soc., 115, 6029, 10.1021/ja00067a019

Ingold, 1993, Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids-unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein, Proc. Natl. Acad. Sci. USA., 90, 45, 10.1073/pnas.90.1.45

Lynch, 1995, Reduction of copper, but not iron, by human low density lipoprotein (LDL)-implications for metal ion-dependent oxidative modification of LDL, J. Biol. Chem., 270, 5158, 10.1074/jbc.270.10.5158

Kontush, 1996, α-Tocopherol as a reductant for Cu(II) in human lipoproteins-triggering role in the initiation of lipoprotein oxidation, J. Biol. Chem., 271, 11106, 10.1074/jbc.271.19.11106

Frei, 1993, Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation, J. Lipid. Res., 34, 2135, 10.1016/S0022-2275(20)35354-2

Thomas, 1994, Involvement of preexisting lipid hydroperoxides in Cu2+-stimulated oxidation of low-density lipoprotein, Arch. Biochem. Biophys., 315, 244, 10.1006/abbi.1994.1496

Miotti, 1987, The requirement for iron(III) in the initiation of lipid peroxidation by iron(II) and hydrogen peroxide, J. Biol. Chem., 262, 1098, 10.1016/S0021-9258(19)75755-X

Kuzuya, 1992, Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein, Biochem. Biophys. Acta., 1123, 334, 10.1016/0005-2760(92)90015-N

Gieseg, 1994, Low density lipoprotein in saturable by pro-oxidant copper, FEBS. Lett., 343, 188, 10.1016/0014-5793(94)80553-9

Ziouzenkova, 1996, Factors affecting resistance of low density lipoproteins to oxidation, Lipids, 31, 71, 10.1007/BF02637054

Chen, 1997, The effect of histidine modification on copper-dependent lipid peroxidation in human low-density lipoprotein, Redox. Rep., 3, 175, 10.1080/13510002.1997.11747106

Wagner, 1997, Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL, Arterioscler. Thromb. Vasc. Biol., 17, 3338, 10.1161/01.ATV.17.11.3338

Heinecke, 1997, Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis, Curr. Opin. Lipidol., 8, 268, 10.1097/00041433-199710000-00005

Morrow, 1996, The isoprostanes: current knowledge and directions for future research, Biochem. Pharmmacol., 51, 1, 10.1016/0006-2952(95)02072-1

Patrono, 1997, Isoprostanes: potential markers of oxidant stress in atherothrombotic disease, Arterioscler. Thromb. Vasc. Biol., 17, 2309, 10.1161/01.ATV.17.11.2309

Leuwenburgh, 1997, Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques, J. Biol. Chem., 272, 3520, 10.1074/jbc.272.6.3520

Huggins, 1993, Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation, J. Biol. Chem., 268, 12341, 10.1016/S0021-9258(18)31395-4

Bothwell, 1979

Danks, 1989, Disorders of copper transport, 1411

Miller, 1994, Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease, J. Am. Med. Assoc., 272, 231, 10.1001/jama.272.3.231

Ascherio, 1994, Are body iron stores related to the risk of coronary heart disease?, New. Eng. J. Med., 330, 1152, 10.1056/NEJM199404213301611

Smith, 1992, Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions, Biochem. J., 286, 901, 10.1042/bj2860901

Swain, 1995, Prooxidant iron and copper, with ferroxidase and xanthine oxidase activity in human atherosclerotic material, FEBS. Let., 368, 513, 10.1016/0014-5793(95)00726-P

Lamb, 1995, Transition metals within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages, FEBS. Let., 374, 12, 10.1016/0014-5793(95)01068-P

Dabbagh, 1997, Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit, Arterioscler. Thromb. Vasc. Biol., 17, 2638, 10.1161/01.ATV.17.11.2638

Araujo, 1995, Iron overload augments the development of atherosclerotic lesions in rabbits, Arterioscler. Thromb. Vasc. Biol., 15, 1172, 10.1161/01.ATV.15.8.1172

Yamamoto, 1992, Mammalian lipoxygenases: molecular structures and functions, Biochem. Biophys. Acta., 1128, 117, 10.1016/0005-2760(92)90297-9

Sparrow, 1988, Enzymatic modification of LDL by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification, J. Lipid. Res., 29, 745, 10.1016/S0022-2275(20)38493-5

Parthasarathy, 1989, A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, Proc. Natl. Acad. Sci. USA., 86, 1046, 10.1073/pnas.86.3.1046

Jessup, 1991, 5-Lipoxygenase is not essential for macrophage mediated oxidation of LDL, Biochem. J., 278, 163, 10.1042/bj2780163

Sparrow, 1991, Cellular oxidative modification of LDL does not require lipoxygenases, Proc. Natl. Acad. Sci. USA., 89, 128, 10.1073/pnas.89.1.128

Yla-Herttuala, 1987, Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions, Proc. Natl. Acad. Sci. USA., 87, 6959, 10.1073/pnas.87.18.6959

Yla-Herttuala, 1995, Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein, J. Clin. Invest., 95, 2692, 10.1172/JCI117971

Benz, 1995, Enhanced levels of lipoperoxides in low density lipoprotein incubated with fibroblasts expressing high levels of human 15-lipoxygenase, J. Biol. Chem., 270, 5191, 10.1074/jbc.270.10.5191

Sigari, 1997, Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL, Arterioscler. Thromb. Vasc. Biol., 17, 3639, 10.1161/01.ATV.17.12.3639

Belkner, 1993, Oxygenation of lipoproteins by mammalian lipoxygenases, Eur. J. Biochem., 213, 251, 10.1111/j.1432-1033.1993.tb17755.x

Folcik, 1995, Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques, J. Clin. Invest., 96, 504, 10.1172/JCI118062

Kuhn, 1997, In vivo action of 15-lipoxygenase in early stages of human atherosclerosis, J. Clin. Invest., 99, 888, 10.1172/JCI119253

Rao, 1994, The lipoxygenase activity of myoglobin, J. Biol. Chem., 269, 7210, 10.1016/S0021-9258(17)37269-1

Moncada, 1991, Nitric oxide: Physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43, 109

Cooke, 1994, Is NO an endogenous antiatherogenic molecule?, Arterioscler. Thromb., 14, 653, 10.1161/01.ATV.14.5.653

Beckman, 1990, Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA., 87, 1620, 10.1073/pnas.87.4.1620

Graham, 1993, Peroxynitrite modifications of LDL leads to recognition by the macrophage scavenger receptor, FEBS. Lett., 330, 181, 10.1016/0014-5793(93)80269-Z

Beckman, 1994, Oxidative chemistry of peroxynitrite, Methods. Enzymol., 233, 229, 10.1016/S0076-6879(94)33026-3

Beckman, 1994, Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry, Biol. Chem. Hoppe-Seyler., 375, 81, 10.1515/bchm3.1994.375.2.81

Jessup, 1992, The participation of nitric oxide in cell free and its restriction of macrophage-mediated oxidation of low-density lipoprotein, Biochim. Biophys. Acta., 1180, 73, 10.1016/0925-4439(92)90029-M

Yates, 1992, A protective role for nitric oxide in the oxidative modification of low density lipoprotein by mouse macrophages, FEBS. Lett., 309, 135, 10.1016/0014-5793(92)81081-V

Hogg, 1993, Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis, FEBS. Lett., 334, 170, 10.1016/0014-5793(93)81706-6

Rubbo, 1995, Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives, Arch. Biochem. Biophys., 324, 1, 10.1006/abbi.1995.9935

Aji, 1997, l-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice, Circulation, 95, 430, 10.1161/01.CIR.95.2.430

Leeuwenburgh, 1997, Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerosis, J. Biol. Chem., 272, 1433, 10.1074/jbc.272.3.1433

Klebanoff, 1980, Oxygen metabolism and the toxic properties of phagocytes, Ann. Int. Med., 93, 480, 10.7326/0003-4819-93-3-480

Hurst, 1989, Leukocytic oxygen activation and microbicidal oxidative toxins, CRC. Crit. Rev. Biochem. Mol. Biol., 24, 271, 10.3109/10409238909082555

Daugherty, 1994, Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions, J. Clin. Invest., 94, 437, 10.1172/JCI117342

Hazell, 1996, Presence of hypochlorite-modified proteins in human atherosclerotic lesions, J. Clin. Invest., 97, 1535, 10.1172/JCI118576

Zeng, 1992, X-ray crystal structure of canine myeloperoxidase at 3Å resolution, J. Mol. Biol., 226, 185, 10.1016/0022-2836(92)90133-5

Ator, 1987, Structure and catalytic mechanism of horseradish peroxidase. Regiospecific meso alkylation of the prosthetic heme group by alkylhydrazines, J. Biol. Chem., 262, 14954, 10.1016/S0021-9258(18)48121-5

Aeschbach, 1976, Formation of dityrosine cross-links in proteins by oxidation of tyrosine residues, Biochem. Biophys. Acta., 439, 292

Wieland, 1993, Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation?, Proc. Natl. Acad. Sci. USA., 90, 5929, 10.1073/pnas.90.13.5929

Heinecke, 1993, Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages, J. Biol. Chem., 268, 4069, 10.1016/S0021-9258(18)53581-X

Heinecke, 1993, Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins, J. Clin. Invest., 91, 2866, 10.1172/JCI116531

Francis, 1993, Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells, Proc. Natl. Acad. Sci. USA., 90, 6631, 10.1073/pnas.90.14.6631

Savenkova, 1994, Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein, J. Biol. Chem., 269, 20394, 10.1016/S0021-9258(17)32005-7

Karthein, 1988, Higher oxidation states of prostaglandin H synthase, Eur. J. Biochem., 171, 313, 10.1111/j.1432-1033.1988.tb13792.x

Buettner, 1993, The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate, Arch. Biochem. Biophys., 300, 535, 10.1006/abbi.1993.1074

Foti, 1994, The surprisingly high reactivity of phenoxyl radicals, J. Am. Chem. Soc., 116, 9440, 10.1021/ja00100a005

Harrison, 1976, Studies on the chlorinating activity of myeloperoxidase, J. Biol. Chem., 251, 1371, 10.1016/S0021-9258(17)33749-3

Foote, 1981, Assessment of chlorination by human neutrophils, Nature, 301, 715, 10.1038/301715a0

Weiss, 1986, Brominating oxidants generated by human eosinophils, Science, 234, 200, 10.1126/science.3018933

Hazen, 1996, Human neutrophils employ chlorine gas as an oxidant during phagocytosis, J. Clin. Invest., 98, 1283, 10.1172/JCI118914

Heinecke, 1994, Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes, Biochemistry, 33, 10127, 10.1021/bi00199a041

Hazen, 1996, Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols, J. Biol. Chem., 271, 23080, 10.1074/jbc.271.38.23080

Hazen, 1997, 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima, J. Clin. Invest., 99, 2075, 10.1172/JCI119379

Eiserich, 1996, Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: a novel mechanism for nitric oxide-mediated protein modification, J. Biol. Chem., 271, 19199, 10.1074/jbc.271.32.19199

Eiserich, 1998, Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature, 391, 393, 10.1038/34923

Shen, 1996, Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development, J. Clin. Invest., 98, 2201, 10.1172/JCI119029

Parthasarathy, 1986, Probucol inhibits oxidative modification of low density lipoprotein, J. Clin. Invest., 77, 641, 10.1172/JCI112349

Kita, 1987, Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia, Proc. Natl. Acad. Sci. USA., 84, 5928, 10.1073/pnas.84.16.5928

Carew, 1987, Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, Proc. Natl. Acad. Sci. USA., 84, 7725, 10.1073/pnas.84.21.7725

Sparrow, 1992, Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N-diphenyl-phenylenediamine, J. Clin. Invest., 89, 1885, 10.1172/JCI115793

Bjorkhem I, Henriksson-Freyschusi, Breuer O, Diczfalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 1991;11:15.

Tangirala, 1995, Effect of the antioxidant N,N′-diphenyl-1, 4-phenylenediamine (DPPD) on atherosclerosis in apo E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 15, 1625, 10.1161/01.ATV.15.10.1625

Bocan, 1994, Atherosclerotic lesion development in hypercholesterolemic Japanese quail following probucol treatment: a biochemical and morphologic evaluation, Pharmacol. Res., 29, 65, 10.1016/1043-6618(94)80099-5

Sasahara, 1994, Inhibition of hypercholesterolemia-induced atherosclerosis in nonhuman primate by probucol. I. Is the extend of atherosclerosis related to resistance of LDL to oxidation?, J. Clin. Invest., 94, 155, 10.1172/JCI117301

Kleinveld, 1994, Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, Arterioscler. Thromb., 14, 1386, 10.1161/01.ATV.14.8.1386

Daugherty, 1989, Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits, Br. J. Pharmacol., 98, 612, 10.1111/j.1476-5381.1989.tb12635.x

Nagano, 1992, Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit-long-term antiatherogenic effect and effects on established plaques, Atherosclerosis, 92, 131, 10.1016/0021-9150(92)90272-I

Shaish, 1995, Carotene inhibits atherosclerosis in hypercholesterolemic rabbits, J. Clin. Invest., 96, 2075, 10.1172/JCI118256

Kleinveld, 1995, Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, Arterioscler. Thromb. Vasc. Biol., 15, 290, 10.1161/01.ATV.15.2.290

Hazell, 1997, Tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein, FEBS. Lett., 414, 541, 10.1016/S0014-5793(97)01066-1

Parthasarathy, 1992, Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative, J. Clin. Invest., 89, 1618, 10.1172/JCI115757

Navab, 1991, Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocytes chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J. Clin. Invest., 88, 2039, 10.1172/JCI115532

Waldeck, 1996, Radical-initiated lipid peroxidation in low density lipoproteins-insights obtained from kinetic modeling, Chem. Res. Toxicol., 9, 954, 10.1021/tx960057s

Zhang, 1997, Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice, J. Clin. Invest., 99, 2858, 10.1172/JCI119479

Reavens, 1992, Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans, Arterioscler. Thromb., 12, 318, 10.1161/01.ATV.12.3.318

Hara, 1992, Probucol pretreatement enhances the chemotaxis of mouse peritoneal macrophages, Arterioscler. Thromb., 12, 593, 10.1161/01.ATV.12.5.593

Franceschi, 1991, Probucol increases cholesteryl ester transfer protein activity in hypercholesterolemic patients, Eur. J. Clin. Invest., 21, 348

Suzuki, 1997, Oxidants as stimulators of signal transduction, Free. Radic. Biol. Med., 22, 269, 10.1016/S0891-5849(96)00275-4

Devaraj, 1996, The effects of α-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 β secretion, and monocyte adhesion to endothelium, J. Clin. Invest., 98, 756, 10.1172/JCI118848

Fruebis, 1994, A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits, J. Clin. Invest., 94, 392, 10.1172/JCI117334

Fruebis, 1997, Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants, J. Lipid. Res., 38, 2455, 10.1016/S0022-2275(20)30030-4

Keaney, 1993, Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits, Proc. Natl. Acad. Sci. USA., 90, 11880, 10.1073/pnas.90.24.11880

Keaney, 1994, Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits, J. Clin. Invest., 93, 844, 10.1172/JCI117039

Suarna, 1995, Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate, Arterioscler. Thromb. Vasc. Biol., 15, 1616, 10.1161/01.ATV.15.10.1616

Heinecke, 1998, Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?, Am. J. Hum. Genet., 62, 20, 10.1086/301691

Tall, 1990, Plasma high density lipoproteins, J. Clin. Invest., 86, 379, 10.1172/JCI114722

Oram, 1996, Apolipoprotein-mediated removal of cellular cholesterol and phospholipids, J. Lipid. Res., 37, 2473, 10.1016/S0022-2275(20)37453-8

Parthasarathy, 1990, High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein, Biochem. Biophys. Acta., 1044, 275, 10.1016/0005-2760(90)90314-N

Mackness, 1991, Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein, FEBS. Lett., 286, 152, 10.1016/0014-5793(91)80962-3

Watson, 1995, Protective effect of high-density lipoprotein associated PON: inhibition of the biological activity of minimally oxidized low density lipoproteins, J. Clin. Invest., 96, 2882, 10.1172/JCI118359

Berliner, 1990, Minimally modified low density lipoprotein stimulates monocyte endothelial interactions, J. Clin. Invest., 85, 1260, 10.1172/JCI114562

Shig, 1996, Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model, J. Clin. Invest., 97, 1630, 10.1172/JCI118589

Stephens, 1996, Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet, 347, 781, 10.1016/S0140-6736(96)90866-1

Gaziano, 1992, Vitamin antioxidants and cardiovascular disease, Curr. Opin. Lipidol., 3, 91, 10.1097/00041433-199208000-00008

Jha, 1995, The antioxidant vitamins and cardiovascular disease-a critical review of epidemiological and clinical trial data, Ann. Int. Med., 123, 860, 10.7326/0003-4819-123-11-199512010-00009

Stampfer, 1993, Vitamin E consumption and the risk of coronary disease in women, New. Eng. J. Med., 328, 1444, 10.1056/NEJM199305203282003

Rimm, 1993, Vitamin E consumption and the risk of coronary heart disease in men, New. Eng. J. Med., 328, 1450, 10.1056/NEJM199305203282004

Walldius, 1994, The effect of probucol on femoral atherosclerosis: the probucol quantitative regression Swedish trial (PQRST), Am. J. Cardiol., 74, 875, 10.1016/0002-9149(94)90579-7

1994, The Effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers, New. Eng. J. Med., 330, 1029, 10.1056/NEJM199404143301501

Hennekens, 1996, Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease, New. Eng. J. Med., 334, 1145, 10.1056/NEJM199605023341801

Devaraj, 1997, Dose-response comparison of RRR-α-tocopherol and all-racemic α-tocopherol on LDL oxidation, Arterioscler. Thromb. Vasc. Biol., 17, 2273, 10.1161/01.ATV.17.10.2273

Tardif, 1997, Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group, New. Eng. J. Med., 337, 365, 10.1056/NEJM199708073370601

O’Keefe, 1996, Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty, Am. J. Cardiol., 77, 649, 10.1016/S0002-9149(97)89325-3

Schneider, 1993, Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis, Circulation, 88, 628, 10.1161/01.CIR.88.2.628

Levine, 1996, Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease, Circulation, 93, 1107, 10.1161/01.CIR.93.6.1107

Hornig, 1998, Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure, Circulation, 97, 363, 10.1161/01.CIR.97.4.363

Suzuki, 1997, A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection, Nature, 386, 6622, 10.1038/386292a0

Davies, 1997, The composition of coronary artery plaques, New. Eng. J. Med., 336, 1312, 10.1056/NEJM199705013361809

Freedman, 1996, Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism, Circulation, 94, 2434, 10.1161/01.CIR.94.10.2434